Published in J Neurooncol on September 24, 2012
A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol (2014) 0.98
Progress in the biological understanding and management of breast cancer-associated central nervous system metastases. Oncologist (2013) 0.93
Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget (2015) 0.87
Rationale for the use of upfront whole brain irradiation in patients with brain metastases from breast cancer. Int J Mol Sci (2014) 0.81
Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. Neuro Oncol (2016) 0.77
Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis. BMC Cancer (2014) 0.76
Methods and results of local treatment of brain metastases in patients with breast cancer. Contemp Oncol (Pozn) (2017) 0.75
Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases. Front Oncol (2015) 0.75
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med (2005) 28.25
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol (2009) 9.90
Gene-expression signatures in breast cancer. N Engl J Med (2009) 9.23
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA (1998) 6.49
Metastatic behavior of breast cancer subtypes. J Clin Oncol (2010) 6.17
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol (2010) 6.15
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys (2000) 5.06
Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol (2004) 4.51
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer (2003) 4.47
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys (2000) 3.00
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res (2009) 2.90
Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol (2007) 2.59
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol (2009) 2.34
Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol (2011) 1.99
Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys (2008) 1.94
Radiation-induced brain injury: A review. Front Oncol (2012) 1.91
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys (2011) 1.74
HER-2/neu expression in primary and metastatic breast cancer. Breast Cancer Res Treat (2008) 1.67
Determinants and prognoses of locoregional and distant progression in breast cancer. Int J Radiat Oncol Biol Phys (2003) 1.49
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer (2009) 1.30
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg (2010) 1.26
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. Eur J Cancer (2004) 1.19
Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol (1999) 1.13
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys (2007) 1.10
The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. Int J Radiat Oncol Biol Phys (2009) 1.05
The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg (2012) 0.94
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases. Int J Radiat Oncol Biol Phys (2012) 0.89
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol (2011) 4.23
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res (2006) 3.83
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol (2006) 3.53
Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol (2007) 3.34
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol (2003) 3.18
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
Retrospective analysis of imaging techniques for treatment planning and monitoring of obliteration for gamma knife treatment of cerebral arteriovenous malformation. Neurosurgery (2012) 2.66
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol (2014) 2.42
The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2007) 2.25
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Radiation-induced brain injury: A review. Front Oncol (2012) 1.91
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol (2003) 1.76
A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion (2008) 1.71
Small cell lung cancer: have we made any progress over the last 25 years? Oncologist (2007) 1.62
Pediatric CSI: are protons the only ethical approach? Int J Radiat Oncol Biol Phys (2013) 1.58
Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys (2010) 1.58
Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol (2006) 1.47
Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg (2006) 1.47
Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int J Radiat Oncol Biol Phys (2008) 1.43
Dosimetry and cancer control after low-dose-rate prostate brachytherapy. Int J Radiat Oncol Biol Phys (2005) 1.38
Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem (2009) 1.36
Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol (2005) 1.36
Specific issues in small animal dosimetry and irradiator calibration. Int J Radiat Biol (2011) 1.32
Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol (2007) 1.31
Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother (2009) 1.28
Early increase in osteoclast number in mice after whole-body irradiation with 2 Gy X rays. Radiat Res (2008) 1.26
Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg (2010) 1.26
Sexual problems in younger women after breast cancer surgery. J Clin Oncol (2006) 1.25
Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res (2004) 1.24
Nightmares and dysfunctional beliefs about sleep mediate the effect of insomnia symptoms on suicidal ideation. J Clin Sleep Med (2013) 1.24
Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol (2014) 1.24
MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells. Am J Physiol Renal Physiol (2008) 1.21
A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Int J Radiat Oncol Biol Phys (2007) 1.21
DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol (2008) 1.20
Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr (2011) 1.20
Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations. Bone (2009) 1.20
DNA damage and breast cancer risk. Carcinogenesis (2003) 1.19
Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer (2008) 1.19
A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure. Biomed Eng Online (2011) 1.17
Association of type 1 diabetes with month of birth among U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.17
Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen (2002) 1.16
Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy. J Neurooncol (2006) 1.15
Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia. Clin Cancer Res (2002) 1.15
Intracranial nonthermal irreversible electroporation: in vivo analysis. J Membr Biol (2010) 1.15
Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review. J Stroke Cerebrovasc Dis (2007) 1.14
Using a computer to teach patients about fecal occult blood screening. A randomized trial. J Gen Intern Med (2005) 1.14
Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am J Clin Oncol (2005) 1.13
Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates. PLoS One (2010) 1.13
Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett (2003) 1.13
Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys (2012) 1.13
Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart (2011) 1.12
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis (2007) 1.10
Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase. Biochemistry (2004) 1.10
Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cancer Res (2010) 1.08
Cadmium and prostate cancer: a critical epidemiologic analysis. Cancer Invest (2005) 1.08
Brain metastases. Curr Probl Surg (2004) 1.07
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys (2011) 1.07
Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat (2013) 1.06
An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J Neurosurg (2003) 1.06
Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiat Res (2012) 1.06
Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg (2015) 1.04
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys (2004) 1.03
Symptom clusters in patients with newly-diagnosed brain tumors. J Support Oncol (2007) 1.02
Rural-urban disparities in health status among US cancer survivors. Cancer (2012) 1.02
Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology (2013) 1.02
Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther (2005) 1.02
Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol (2012) 1.01
Impact of restricting enrollment in stroke genetics research to adults able to provide informed consent. Stroke (2008) 1.00
Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery (2013) 0.99